CNSP | CNS Pharmaceuticals (NASDAQ:CNSP) Shares Up 17.4%

CNS Pharmaceuticals, Inc.(NASDAQ:CNSP) traded up 17.4% on Friday .The company traded as high as $2.30 and last traded at $2.16.205,792 shares traded hands during trading, an increase of 79% from the average session volume of 115,133 shares.The stock had previously closed at $1.84.Separately, LADENBURG THALM/SH SH assumed coverage on CNS […]Daily Political

CNSP | CNS Pharmaceuticals (NASDAQ: CNSP) Announces Completion of Drug Manufacturing for Brain Cancer Trial

Houston-based CNS Pharmaceuticals is preparing to launch Phase 2 clinical testing of a novel brain cancer-fighting drug candidate called Berubicin early next year The biopharmaceutical company recently announced that a U.S.-based company contracted to make Berubicin has completed its production process and an Italian company working on a dual track in Europe is expected to […]